Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only

Home/PA/Erie

Updated September 2026 from ClinicalTrials.gov

Paid Clinical Trials in Erie, PA

Studies commonly pay $75 to $4,500 per completed study

90 clinical trials are currently recruiting participants within 30 miles of Erie. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

90studies recruiting

4+research centers nearby

4condition categories

Live from the NIH registry

Studies recruiting near Erie right now

Top 25 of 90 recruiting studies, sorted by proximity — each links to its official registry page

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8 Phase 3 Interventional 1,209 participants sought

UPMC Hillman Cancer Center Erie — Erie, Pennsylvania (1.1 mi) · Sponsor: NRG Oncology

See eligibility & contact on ClinicalTrials.gov (NCT05946213)

A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis

Uterine Fibroids, Endometriosis Phase 3 Interventional 1,000 participants sought

Erie — Erie, Pennsylvania (1.1 mi) · Sponsor: Sumitomo Pharma Switzerland GmbH

See eligibility & contact on ClinicalTrials.gov (NCT05862272)

High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer

Head and Neck Squamous Cell Carcinoma, Stage I Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8 Phase 3 Interventional 228 participants sought

UPMC Hillman Cancer Center Erie — Erie, Pennsylvania (1.1 mi) · Sponsor: Alliance for Clinical Trials in Oncology

See eligibility & contact on ClinicalTrials.gov (NCT06992427)

Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial

Metastatic Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8 Phase 2 Interventional 240 participants sought

UPMC Hillman Cancer Center Erie — Erie, Pennsylvania (1.1 mi) · Sponsor: NRG Oncology

See eligibility & contact on ClinicalTrials.gov (NCT05327686)

Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)

Malignant Female Reproductive System Neoplasm, Malignant Solid Neoplasm Phase 2 Interventional 70 participants sought

UPMC Hillman Cancer Center Erie — Erie, Pennsylvania (1.1 mi) · Sponsor: National Cancer Institute (NCI)

See eligibility & contact on ClinicalTrials.gov (NCT06126276)

Phase 3 Study to Assess Efficacy, Safety & Tolerability of OCU410 For Geographic Atrophy Secondary to Dry AMD

Dry Age-related Macular Degeneration Phase 3 Interventional 237 participants sought

Erie Retina Research — Erie, Pennsylvania (1.1 mi) · Sponsor: Ocugen

See eligibility & contact on ClinicalTrials.gov (NCT07770828)

Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study

Muscle Invasive Bladder Urothelial Carcinoma, Muscle Invasive Renal Pelvis Urothelial Carcinoma Phase 2, Phase 3 Interventional 992 participants sought

UPMC Hillman Cancer Center Erie — Erie, Pennsylvania (1.1 mi) · Sponsor: National Cancer Institute (NCI)

See eligibility & contact on ClinicalTrials.gov (NCT05987241)

Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma

Endometrial Carcinoma, Endometrial Clear Cell Adenocarcinoma Phase 3 Interventional 360 participants sought

Saint Vincent Hospital — Erie, Pennsylvania (1.1 mi) · Sponsor: National Cancer Institute (NCI)

See eligibility & contact on ClinicalTrials.gov (NCT05256225)

Dichoptic Treatment for Amblyopia in Children 8 to 12 Years of Age

Amblyopia Phase 3 Interventional 252 participants sought

Pediatric Ophthalmology of Erie — Erie, Pennsylvania (1.1 mi) · Sponsor: Jaeb Center for Health Research

See eligibility & contact on ClinicalTrials.gov (NCT06524882)

Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer

Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7 Phase 2, Phase 3 Interventional 613 participants sought

UPMC Hillman Cancer Center Erie — Erie, Pennsylvania (1.1 mi) · Sponsor: National Cancer Institute (NCI)

See eligibility & contact on ClinicalTrials.gov (NCT01810913)

A Study in Adults With Geographic Atrophy

Geographic Atrophy Phase 2 Interventional 300 participants sought

Erie Retina Research — Erie, Pennsylvania (1.1 mi) · Sponsor: Sitala Bio LTD

See eligibility & contact on ClinicalTrials.gov (NCT07606365)

Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery

Head and Neck Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma Phase 2 Interventional 189 participants sought

UPMC Hillman Cancer Center Erie — Erie, Pennsylvania (1.1 mi) · Sponsor: ECOG-ACRIN Cancer Research Group

See eligibility & contact on ClinicalTrials.gov (NCT02734537)

A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

Geographic Atrophy, Macular Degeneration Phase 2, Phase 3 Interventional 274 participants sought

Erie Retina Research — Erie, Pennsylvania (1.1 mi) · Sponsor: Janssen Research & Development, LLC

See eligibility & contact on ClinicalTrials.gov (NCT06635148)

Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment

Multiple conditions Phase 3 Interventional 158 participants sought

UPMC Hillman Cancer Center Erie — Erie, Pennsylvania (1.1 mi) · Sponsor: National Cancer Institute (NCI)

See eligibility & contact on ClinicalTrials.gov (NCT06589804)

Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer

Locally Advanced Cervical Adenocarcinoma, Locally Advanced Cervical Adenosquamous Carcinoma Phase 3 Interventional 336 participants sought

UPMC Hillman Cancer Center Erie — Erie, Pennsylvania (1.1 mi) · Sponsor: National Cancer Institute (NCI)

See eligibility & contact on ClinicalTrials.gov (NCT07061977)

Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma

Retroperitoneal Sarcoma, Liposarcoma Phase 3 Interventional 250 participants sought

Saint Vincent Hospital — Erie, Pennsylvania (1.1 mi) · Sponsor: European Organisation for Research and Treatment of Cancer - EORTC

See eligibility & contact on ClinicalTrials.gov (NCT04031677)

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

Diabetes Mellitus, Type 2, Hypertension Phase 3 Interventional 11,800 participants sought

Great Lakes Medical Research — Westfield, New York (29.0 mi) · Sponsor: Boehringer Ingelheim

See eligibility & contact on ClinicalTrials.gov (NCT07064473)

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Multiple conditions Phase 2 Interventional 314 participants sought

UPMC Hillman Cancer Center Erie — Erie, Pennsylvania (1.1 mi) · Sponsor: National Cancer Institute (NCI)

See eligibility & contact on ClinicalTrials.gov (NCT03866382)

A Clinical Study Evaluating Licaminlimab for Dry Eye Disease

Dry Eye Disease (DED) Phase 2, Phase 3 Interventional 160 participants sought

Erie Retina Research — Erie, Pennsylvania (1.1 mi) · Sponsor: Oculis

See eligibility & contact on ClinicalTrials.gov (NCT07548632)

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Stage I Breast Cancer Phase 3 Interventional 1,670 participants sought

Saint Vincent Hospital — Erie, Pennsylvania (1.1 mi) · Sponsor: NRG Oncology

See eligibility & contact on ClinicalTrials.gov (NCT04852887)

A Research Study Comparing Different Ways of Increasing the Dose of NNC0662-0419 in Participants With Obesity

Obesity Phase 2 Interventional 230 participants sought

Great Lakes Medical Research — Westfield, New York (29.0 mi) · Sponsor: Novo Nordisk A/S

See eligibility & contact on ClinicalTrials.gov (NCT07639021)

Study of ALK-001 on the Progression of Stargardt Disease

Stargardt Disease Phase 3 Interventional 230 participants sought

Erie Retina Research — Erie, Pennsylvania (1.1 mi) · Sponsor: Alkeus Pharmaceuticals, Inc.

See eligibility & contact on ClinicalTrials.gov (NCT07419334)

Phase I Study to Assess the Safety and Efficacy of OCU200 for Center-Involved Diabetic Macular Edema (DME)

Center Involved Diabetic Macular Edema, Diabetic Macular Edema Phase 1 Interventional 24 participants sought

Erie Retina Research, LLC — Erie, Pennsylvania (1.1 mi) · Sponsor: Ocugen

See eligibility & contact on ClinicalTrials.gov (NCT05802329)

COMO: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME

Diabetic Macular Edema, DME Phase 3 Interventional 240 participants sought

Erie Retina Research — Erie, Pennsylvania (1.1 mi) · Sponsor: EyePoint Pharmaceuticals, Inc.

See eligibility & contact on ClinicalTrials.gov (NCT07449936)

A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)

Macular Degeneration, Age-Related Macular Degeneration Phase 2, Phase 3 Interventional 960 participants sought

Erie Retina Research — Erie, Pennsylvania (1.1 mi) · Sponsor: EyeBiotech Ltd.

See eligibility & contact on ClinicalTrials.gov (NCT07496567)

Actively enrolling

Studies you may be able to join near Erie

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

See which clinical studies you may qualify for

A partner research network matches volunteers with studies that are currently enrolling in the United States. You answer a few screening questions about your health and where you live; if a study looks like a fit, its team contacts you to confirm eligibility.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Google-rated

Top-rated research centers in Erie

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Square-1 Clinical Research

2221-A Ebco Dr, Erie, PA 16506

(814) 838-8724

Website

Erie Retina Research

★ 4.8

2005 W 8th St, Erie, PA 16505

(814) 200-9152

Website

"Dr. Almeida is always awesome!"

— Joe Ropelewski, 5★

Susan Hirt Hagen Center for Community Outreach, Research, and Evaluation (CORE)

★ 5.0

5343 Station Rd, Erie, PA 16510

(814) 898-6297

Website

"Great tour today! Props to Hannah, our guide"

— Jeanie Sing, 5★

Great Lakes Medical Research

138 E Main St, Westfield, NY 14787

(716) 326-4890

Website

Clinical trials in Erie: what's recruiting

The Erie area currently has 90 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Erie, the most active research areas are:

Cancer & Oncology12 studies
Diabetes & Metabolism4 studies
Liver & Kidney3 studies
Heart & Vascular2 studies

Every listing shows the study phase, the recruiting site and its distance from Erie, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Erie

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Erie participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

Do I need to be sick to join a clinical trial in Erie?

No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.

Are clinical trials in Erie safe?

Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.

Is compensation for clinical trials taxable?

In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.

What is the difference between a research center and a hospital study in Erie?

Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.

Can I be in more than one clinical trial at a time?

Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Erie typically complete one or two studies per year.

Paid clinical trials near Erie

Other metros within reach

Youngstown, OH81 Buffalo, NY521 Pittsburgh, PA1,237 Cleveland, OH1,412 Akron, OH393 Canton, OH304 Lorain, OH1,305 Rochester, NY471

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Erie Bladder Issues Due To Spinal Cord Injury in Erie All conditions

More of PA

Philadelphia2,171 Pittsburgh1,237 York441 Lancaster420 Harrisburg399 Reading268 Allentown229 Scranton92

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

Get free trial alerts